Table 2.
Elicited numerical utilities of the 16 joint (Efficacy, Toxicity) outcomes.
| Toxicity |
Disease Status (Efficacy)
|
|||
|---|---|---|---|---|
| PD | SD1 | SD2 | PR/CR | |
| Mild | 25 | 55 | 80 | 100 |
| Moderate | 20 | 35 | 70 | 90 |
| High | 10 | 25 | 50 | 70 |
| Severe | 0 | 10 | 25 | 40 |
Elicited numerical utilities of the 16 joint (Efficacy, Toxicity) outcomes.
| Toxicity |
Disease Status (Efficacy)
|
|||
|---|---|---|---|---|
| PD | SD1 | SD2 | PR/CR | |
| Mild | 25 | 55 | 80 | 100 |
| Moderate | 20 | 35 | 70 | 90 |
| High | 10 | 25 | 50 | 70 |
| Severe | 0 | 10 | 25 | 40 |